Literature DB >> 6330880

Congenital cytomegalovirus infection and disease in Sweden and the relative importance of primary and secondary maternal infections. Preliminary findings from a prospective study.

K Ahlfors, S A Ivarsson, S Harris, L Svanberg, R Holmqvist, B Lernmark, G Theander.   

Abstract

In a prospective Swedish study started in 1977 and still in progress 10 328 newborn infants in an urban district were investigated for cytomegalovirus (CMV) excretion in the urine by the virus isolation test. Congenital infection was found in 50 cases (0.5%). Of 47 infected infants with known clinical status at birth 9 (19%) had hepatomegaly, splenomegaly, jaundice and/or petechiae. The symptoms were moderate or mild. Of the infants followed up, 2 (25%) of 8 neonatally symptomatic ones and 3 (9%) of 35 asymptomatic ones developed neurologic sequelae. Altogether 5 (12%) of 43 had permanent neurologic symptoms corresponding to 0.06% in the general population. The children ranged in age from 6 months to 4 yr at the last examination. 21 mothers of the 47 infants with known status at birth had a confirmed or presumed primary infection, 15 a confirmed or presumed secondary infection and 11 an undetermined type of infection. Of the 5 infants with neurologic sequelae, 1 with a grave psychomotor retardation and deafness was born to a mother with a primary infection in the 1st trimester; 1 infant with a moderate retardation and 3 deaf infants were all exposed to confirmed or presumed secondary maternal infections. Prospective serological studies of maternal sera in early pregnancy would have suspected only the gravely retarded infant to be at risk.

Entities:  

Mesh:

Year:  1984        PMID: 6330880     DOI: 10.3109/00365548409087131

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  25 in total

1.  Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells.

Authors:  Jenny Odeberg; Nina Wolmer; Scott Falci; Magnus Westgren; Ake Seiger; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population.

Authors:  Aparecida Y Yamamoto; Marisa Marcia Mussi-Pinhata; Myriam de Lima Isaac; Fabiana R Amaral; Cristina G Carvalheiro; Davi C Aragon; Alessandra K da Silva Manfredi; Suresh B Boppana; William J Britt
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

3.  A Targeted Approach for Congenital Cytomegalovirus Screening Within Newborn Hearing Screening.

Authors:  Karen B Fowler; Faye P McCollister; Diane L Sabo; Angela G Shoup; Kris E Owen; Julie L Woodruff; Edith Cox; Lisa S Mohamed; Daniel I Choo; Suresh B Boppana
Journal:  Pediatrics       Date:  2017-01-03       Impact factor: 7.124

4.  Congenital cytomegalovirus infection.

Authors:  J M Best
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

5.  Congenital cytomegalovirus infection.

Authors:  D J Morris
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-25

6.  Natural History of Congenital Cytomegalovirus Infection in Highly Seropositive Populations.

Authors:  Marisa Marcia Mussi-Pinhata; Aparecida Yulie Yamamoto
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

7.  Cytomegalovirus viruria and DNAemia in healthy seropositive women.

Authors:  Nitin Arora; Zdenek Novak; Karen B Fowler; Suresh B Boppana; Shannon A Ross
Journal:  J Infect Dis       Date:  2010-11-04       Impact factor: 5.226

Review 8.  Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.

Authors:  Bodo Plachter
Journal:  Med Microbiol Immunol       Date:  2016-08-12       Impact factor: 3.402

Review 9.  Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature.

Authors:  Michael A Gaytant; G Ingrid J G Rours; Eric A P Steegers; Jochem M D Galama; Ben A Semmekrot
Journal:  Eur J Pediatr       Date:  2003-02-13       Impact factor: 3.183

10.  Vaccine prevention of maternal cytomegalovirus infection.

Authors:  Robert F Pass; Changpin Zhang; Ashley Evans; Tina Simpson; William Andrews; Meei-Li Huang; Lawrence Corey; Janie Hill; Elizabeth Davis; Cynthia Flanigan; Gretchen Cloud
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.